KeyCorp reiterated their hold rating on shares of Colgate-Palmolive Company (NYSE:CL) in a report released on Monday morning. KeyCorp also issued estimates for Colgate-Palmolive’s FY2017 earnings at $2.89 EPS.
Several other equities research analysts also recently weighed in on the stock. SunTrust Banks, Inc. raised shares of Colgate-Palmolive from a hold rating to a buy rating and upped their price objective for the stock from $65.00 to $85.00 in a report on Wednesday, October 11th. Royal Bank Of Canada reaffirmed a hold rating and issued a $74.00 price objective on shares of Colgate-Palmolive in a report on Sunday, October 8th. Zacks Investment Research raised shares of Colgate-Palmolive from a hold rating to a buy rating and set a $82.00 price objective for the company in a report on Monday, October 2nd. Jefferies Group LLC reaffirmed a hold rating and issued a $79.00 price objective on shares of Colgate-Palmolive in a report on Thursday, September 28th. Finally, Morgan Stanley raised shares of Colgate-Palmolive from an equal weight rating to an overweight rating and upped their price objective for the stock from $75.00 to $84.00 in a report on Monday, September 25th. One analyst has rated the stock with a sell rating, fifteen have issued a hold rating and four have given a buy rating to the company. The company presently has a consensus rating of Hold and a consensus price target of $76.85.
Shares of Colgate-Palmolive (CL) opened at 74.44 on Monday. The firm has a market cap of $65.57 billion, a PE ratio of 27.66 and a beta of 0.81. The company has a 50 day moving average of $72.75 and a 200 day moving average of $73.23. Colgate-Palmolive has a 52 week low of $63.43 and a 52 week high of $77.27.
Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, July 21st. The company reported $0.72 earnings per share for the quarter, hitting the consensus estimate of $0.72. The business had revenue of $3.83 billion during the quarter, compared to the consensus estimate of $3.89 billion. Colgate-Palmolive had a net margin of 15.83% and a return on equity of 3,121.95%. The company’s quarterly revenue was down .5% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.70 earnings per share. On average, equities research analysts anticipate that Colgate-Palmolive will post $2.90 EPS for the current fiscal year.
TRADEMARK VIOLATION NOTICE: “Colgate-Palmolive Company (CL) Earns “Hold” Rating from KeyCorp” was originally reported by StockNewsTimes and is the sole property of of StockNewsTimes. If you are accessing this news story on another website, it was copied illegally and reposted in violation of United States and international trademark & copyright law. The original version of this news story can be read at https://stocknewstimes.com/2017/10/19/colgate-palmolive-company-cl-earns-hold-rating-from-keycorp.html.
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, November 15th. Shareholders of record on Monday, October 23rd will be issued a dividend of $0.40 per share. The ex-dividend date is Friday, October 20th. This represents a $1.60 annualized dividend and a yield of 2.15%. Colgate-Palmolive’s payout ratio is presently 59.48%.
In other Colgate-Palmolive news, COO Justin Skala sold 74,374 shares of the business’s stock in a transaction dated Thursday, July 27th. The stock was sold at an average price of $72.51, for a total transaction of $5,392,858.74. Following the sale, the chief operating officer now owns 97,177 shares in the company, valued at approximately $7,046,304.27. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director John T. Cahill sold 8,000 shares of the business’s stock in a transaction dated Thursday, July 27th. The stock was sold at an average price of $72.47, for a total value of $579,760.00. Following the sale, the director now owns 31,786 shares in the company, valued at approximately $2,303,531.42. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 214,136 shares of company stock worth $15,416,385. Corporate insiders own 1.02% of the company’s stock.
Hedge funds and other institutional investors have recently bought and sold shares of the business. American Beacon Advisors Inc. acquired a new stake in Colgate-Palmolive during the 1st quarter worth about $102,000. Proficio Capital Partners LLC raised its holdings in Colgate-Palmolive by 16.9% during the 1st quarter. Proficio Capital Partners LLC now owns 1,432 shares of the company’s stock worth $107,000 after buying an additional 207 shares during the period. OLD Second National Bank of Aurora acquired a new stake in Colgate-Palmolive during the 2nd quarter worth about $109,000. Krilogy Financial LLC raised its holdings in Colgate-Palmolive by 23.0% during the 2nd quarter. Krilogy Financial LLC now owns 1,547 shares of the company’s stock worth $115,000 after buying an additional 289 shares during the period. Finally, Harbour Capital Advisors LLC acquired a new stake in Colgate-Palmolive during the 1st quarter worth about $121,000. Hedge funds and other institutional investors own 73.09% of the company’s stock.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with MarketBeat.com's FREE daily email newsletter.